Tabák, A G <br/><br/>
Low serum adiponectin predicts 10-year risk of type 2 diabetes and HbA1c independently of obesity, lipids, and inflammation: Whitehall II study.  [electronic resource] 

 -  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme  Aug 2009 
 - 626-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1439-4286 
<br/><br/><label>Standard No.: </label>10.1055/s-0029-1216359  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adiponectin--blood<br/>Adult<br/>Case-Control Studies<br/>Cohort Studies<br/>Diabetes Mellitus, Type 2--diagnosis<br/>Female<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Inflammation--diagnosis<br/>Lipid Metabolism<br/>Male<br/>Middle Aged<br/>Obesity--diagnosis<br/>Predictive Value of Tests<br/>Risk Factors